Jan 2023 Alzheimer’s News

January 2023 Alzheimer’s News
From presentations at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Congress Nov. 29-Dec. 2 in San Francisco.
There is promising news about the use of C2N Diagnostic’s Precivity AD and Precivity AD2 Blood Tests as Blood-Based biomarkers in the diagnosis of Alzheimer’s Disease. New research shows that neurologists and memory care specialists were better able to evaluate and change medical management of patients with cognitive impairment using the C2N Diagnostic’s Precivity AD Blood Test. Additional research findings confirm excellent performance of the Precivity AD2 Blood Test and p-tau217 Ratio test screening high risk individuals for entry into clinical trials.
You can learn more by going to www.alz.org/help-support/resources or the Alzheimer’s Helpline which is accessible 24/7 via 800-272-3900 and staffed by master’s level clinicians to assist with crisis situations, decision making, and disease information. You can find virtual dementia caregiver resources online at alz.org/covid19help. Tools and support are also available in Spanish.
Want to learn more about the Alzheimer’s Association and what they do here in St. Louis? Visit alz.org and/or contact PUCC’s Faith Outreach Ambassador with the Alzheimer’s Association, Joyce Ruiz at joyceruiz7@gmail.com